Stabilized cyclopropane analogs of the splicing inhibitor FD-895

Journal of Medicinal Chemistry

Volumn 56, Issue 17, 2013, Pages 6576-6582

  Villa, Reymundo ^a   Kashyap, Manoj Kumar ^b   Kumar, Deepak ^b   Kipps, Thomas J ^b,c   Castro, Januario E ^b,c   La Clair, James J ^a   Burkart, Michael D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBAMIC ACID; CYCLOPROPANE; FD 895; MESSENGER RNA; NATURAL PRODUCT; PLADIENOLIDE B; PLADIENOLIDE D; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL LINE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL (TOPIC); GROWTH INHIBITION; HUMAN; IC 50; RNA SPLICING; SOLID TUMOR; SPLICEOSOME;

CHROMATOGRAPHY, LIQUID; CYCLOPROPANES; INHIBITORY CONCENTRATION 50; MACROLIDES; MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; RNA SPLICING;

EID: 84884252262     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm400861t     Document Type: Article

References (28)

1. Butler, M. S. Natural products to drugs: natural product-derived compounds in clinical trials Nat. Prod. Rep. 2008, 25, 475-516
2. Seki-Asano, M.; Okazaki, T.; Yamagishi, M.; Sakai, N.; Takayama, Y.; Hanada, K.; Morimoto, S.; Takatsuki, A.; Mizoue, K. Isolation and characterization of a new 12-membered macrolide FD-895 J. Antibiot. (Tokyo) 1994, 47, 1395-1401
3. Mizui, Y.; Sakai, T.; Iwata, M.; Uenaka, T.; Okamoto, K.; Shimizu, H.; Yamori, T.; Yoshimatsu, K.; Asada, M. Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. III. In vitro and in vivo antitumor activities J. Antibiot. (Tokyo) 2004, 57, 188-196
4. Asai, N.; Kotake, Y.; Niijima, J.; Fukuda, Y.; Uehara, T.; Sakai, T. Stereochemistry of pladienolide B J. Antibiot. (Tokyo) 2007, 60, 364-369
5. Mandel, A. L.; Jones, B. D.; La Clair, J. J.; Burkart, M. D. A synthetic entry to pladienolide B and FD-895 Bioorg. Med. Chem. Lett. 2007, 17, 5159-5164
6. Villa, R.; Mandel, A. L.; Jones, B. D.; La Clair, J. J.; Burkart, M. D. Structure of FD-895 unveiled through total synthesis Org. Lett. 2012, 14, 5396-5399
7. Kanada, R. M.; Itoh, D.; Nagai, M.; Niijima, J.; Asai, N.; Mizui, Y.; Abe, S.; Kotake, Y. Total synthesis of the potent antitumor macrolides pladienolide B and D Angew. Chem., Int. Ed. 2007, 46, 4350-4355
8. Skaanderup, P. R.; Jensen, T. Synthesis of the macrocyclic core of (-)-pladienolide B Org. Lett. 2008, 10, 2821-2824
9. Müller, S.; Mayer, T.; Sasse, F.; Maier, M. E. Synthesis of a pladienolide B analogue with the fully functionalized core structure Org. Lett. 2011, 13, 3940-3943
10. Ghosh, A. K.; Anderson, D. D. Enantioselective Total Synthesis of Pladienolide B: A Potent Spliceosome Inhibitor Org. Lett. 2012, 14, 4730-4733
11. Gundluru, M. K.; Pourpak, A.; Cui, X.; Morris, S. W.; Webb, T. R. Design, synthesis and initial biological evaluation of a novel pladienolide analog scaffold MedChemComm 2011, 2, 904-908
12. Komatsu, M.; Uchiyama, T.; Omura, S.; Cane, D. E.; Ikeda, H. Genome-minimized Streptomyces host for the heterologous expression of secondary metabolism Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 2646-2651
13. Machida, K.; Aritoku, Y.; Tsuchida, T. One-pot fermentation of pladienolide D by Streptomyces platensis expressing a heterologous cytochrome P450 gene J. Biosci. Bioeng. 2009, 106, 596-598
14. Machida, K.; Arisawa, A.; Takeda, S.; Tsuchida, T.; Aritoku, Y.; Yoshida, M.; Ikeda, H. Organization of the biosynthetic gene cluster for the polyketide antitumor macrolide, pladienolide, in Streptomyces platensis Mer-11107 Biosci. Biotechnol. Biochem. 2008, 72, 2946-2952
15. Kotake, Y.; Sagane, K.; Owa, T.; Mimori-Kiyosue, Y.; Shimizu, H.; Uesugi, M.; Ishihama, Y.; Iwata, M.; Mizui, Y. Splicing factor SF3b as a target of the antitumor natural product pladienolide Nat. Chem. Biol. 2007, 3, 570-575
16. Yokoi, A.; Kotake, Y.; Takahashi, K.; Kadowaki, T.; Matsumoto, Y.; Minoshima, Y.; Sugi, N. H.; Sagane, K.; Hamaguchi, M.; Iwata, M.; Mizui, Y. Biological validation that SF3b is a target of the antitumor macrolide pladienolide FEBS J. 2011, 278, 4870-4880
17. Folco, E. G.; Coil, K. E.; Reed, R. The anti-tumor drug E7107 reveals an essential role for SF3b in remodeling U2 snRNP to expose the branch point-binding region Genes Dev. 2011, 25, 440-444
18. Kaida, D.; Motoyoshi, H.; Tashiro, E.; Nojima, T.; Hagiwara, M.; Ishigami, K.; Watanabe, H.; Kitahara, T.; Yoshida, T.; Nakajima, H.; Tani, T.; Horinouchi, S.; Yoshida, M. Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA Nat. Chem. Biol. 2007, 3, 576-583
19. Gao, Y.; Vogt, A.; Forsyth, C. J.; Koide, K. Comparison of splicing factor 3b inhibitors in human cells ChemBioChem. 2013, 14, 49-52
20. Fan, L.; Lagisetti, C.; Edwards, C. C.; Webb, T. R.; Potter, P. M. Sudemycins, novel small molecule analogues of FR901464, induce alternative gene splicing ACS Chem. Biol. 2011, 6, 582-589
21. van Alphen, R. J.; Wiemer, E. A.; Burger, H.; Eskens, F. A. The spliceosome as target for anticancer treatment Br. J. Cancer 2009, 100, 228-232
22. Lagisetti, C.; Pourpak, A.; Jiang, Q.; Cui, X.; Goronga, T.; Morris, S. W.; Webb, T. R. Antitumor compounds based on a natural product consensus pharmacophore J. Med. Chem. 2008, 51, 6220-6224
23. Sumantran, V. N. Cellular chemosensitivity assays: an overview Methods Mol. Biol. 2011, 731, 219-236
24. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 1983, 65, 55-63
25. Marshall, J. A. Chiral allylic and allenic metal reagents for organic synthesis J. Org. Chem. 2007, 72, 8153-8166
26. González-Pérez, M.; Gómez-Bombarelli, R.; Arenas-Valgañón, J.; Pérez-Prior, M. T.; García-Santos, M. P.; Calle, E.; Casado, J. Connecting the chemical and biological reactivity of epoxides Chem. Res. Toxicol. 2012, 25, 2755-2762
27. Zimmer, L. E.; Charette, A. B. Enantioselective synthesis of 1,2,3-trisubstituted cyclopropanes using gem-dizinc reagents J. Am. Chem. Soc. 2009, 131, 15624-15626
28. Kashyap, M. K.; Kumar, D.; Jones, H.; Schwaederle, M.; Ghia, E. G.; Villa, R.; Burkart, M. E.; Kipps, T. J.; Castro, J. E. FD-895 and pladienolide-B Inhibit mRNA splicing and induce apoptosis in xhronic lymphocytic leukemia. Blood (ASH Annual Meeting Abstracts); 2012, 120, 3890.